Tag: olorofim

Interferon-γ and dupilumab effectively treat disseminated coccidioidomycosis infection

Novel antifungal shows promise for patients with refractory disseminated coccidioidomycosis

byAdrian Wongand1 others

July 20, 2026

1. In this single-group, open-label trial, olorofim was associated with a complete or partial clinical response in over 75% of ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

NHS rolls out Microsoft Copilot to 505,000 clinicians
Novel antifungal shows promise for patients with refractory disseminated coccidioidomycosis
2MM: AI Roundup: Food and Drug Administration reviews liver injury prediction tool, Joint Commission launches healthcare artificial intelligence certification, governance playbooks aim to standardize adoption, and pediatric hospitals bring generative tools to the frontline

No Result

View All Result